These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 9934852)
1. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model. Rodríguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852 [TBL] [Abstract][Full Text] [Related]
2. Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology. Rodríguez-Burford C; Steele VE; Anderson AS; Stockard CR; Weiss HL; Eto I; Johanning GL; Grizzle WE; Grubbs CJ Nutr Cancer; 2002; 43(1):67-75. PubMed ID: 12467137 [TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention. Rodríguez-Burford C; Lubet RA; Steele VE; Eto I; Bandy M; Juliana MM; Weiss HL; Grizzle WE; Kelloff GJ; Grubbs CJ Oncol Rep; 2001; 8(2):373-9. PubMed ID: 11182059 [TBL] [Abstract][Full Text] [Related]
4. Influence of delayed administration of retinyl acetate on mammary carcinogenesis. McCormick DL; Moon RC Cancer Res; 1982 Jul; 42(7):2639-43. PubMed ID: 7083156 [TBL] [Abstract][Full Text] [Related]
5. Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis. Crist KA; Wang Y; Lubet RA; Steele VE; Kelloff GJ; You M J Cell Biochem Suppl; 1997; 27():92-9. PubMed ID: 9591198 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682 [TBL] [Abstract][Full Text] [Related]
7. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors. Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393 [TBL] [Abstract][Full Text] [Related]
8. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527 [TBL] [Abstract][Full Text] [Related]
9. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland. Green A; Shilkaitis A; Christov K Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803 [TBL] [Abstract][Full Text] [Related]
10. Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis. Cohen LA; Epstein M; Saa-Pabon V; Meschter C; Zang E Nutr Cancer; 1994; 21(3):271-83. PubMed ID: 8072880 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats. Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention. Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085 [TBL] [Abstract][Full Text] [Related]
13. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats. Lee S; Simpson M; Nimmo M; Xu Z Carcinogenesis; 2004 Oct; 25(10):1879-85. PubMed ID: 15205360 [TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats. Lubet RA; Steele VE; Casebolt TL; Eto I; Kelloff GJ; Grubbs CJ Carcinogenesis; 1994 Dec; 15(12):2775-80. PubMed ID: 8001234 [TBL] [Abstract][Full Text] [Related]
15. Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis. Schaffer EM; Liu JZ; Green J; Dangler CA; Milner JA Cancer Lett; 1996 Apr; 102(1-2):199-204. PubMed ID: 8603370 [TBL] [Abstract][Full Text] [Related]
16. Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer. Shealy YF; Frye JL; Riordan JM; Hill DL; McPhillips M; Wille JJ; Sani BP; Kalin JR; Eto I; Grubbs CJ Anticancer Drug Des; 1997 Jan; 12(1):15-33. PubMed ID: 9051111 [TBL] [Abstract][Full Text] [Related]
17. Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat. Thompson HJ; Becci PJ; Brown CC; Moon RC Cancer Res; 1979 Oct; 39(10):3977-80. PubMed ID: 476636 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen. Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970 [TBL] [Abstract][Full Text] [Related]
19. Dietary effects of conjugated docosahexaenoic acid on N-methyl-N-nitrosourea-induced mammary carcinogenesis in female Sprague-Dawley rats. Danbara N; Uehara N; Shikata N; Takada H; Hada T; Tsubura A Oncol Rep; 2004 Nov; 12(5):1079-85. PubMed ID: 15492796 [TBL] [Abstract][Full Text] [Related]
20. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C? Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]